Shlomit Schaal to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Shlomit Schaal has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.577
-
Nesmith BL, Ihnen M, Schaal S. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea. Retina. 2014 Dec; 34(12):2423-30.
Score: 0.406
-
Jusufbegovic D, Mugavin MO, Schaal S. EVOLUTION OF CONTROLLING DIABETIC RETINOPATHY: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade. Retina. 2015 May; 35(5):929-34.
Score: 0.105
-
Schaal S, Kaplan HJ, Tezel TH. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology. 2008 Dec; 115(12):2199-205.
Score: 0.066